➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Moodys
Mallinckrodt
Dow
AstraZeneca

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Litigation Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

Docket   Get Started for $10 Date Filed 2017-08-16
Court District Court, D. Delaware Date Terminated 2020-07-06
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To
Parties APOTEX CORP.
Patents 10,010,533; 10,052,385; 7,012,066; 8,609,707; 8,791,270; 9,000,021; 9,034,908; 9,144,568; 9,265,831; 9,572,796; 9,572,797; 9,572,887; 9,579,384; 9,597,397; 9,597,398; 9,597,399
Attorneys John D. Cravero
Firms Flaster Greenburg, P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Cephalon, Inc. v. Slayback Pharma Limited Liability Company
The small molecule drugs covered by the patents cited in this case are   Get Started for $10 ,   Get Started for $10 , and   Get Started for $10 .

Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2019-06-26 284 Redacted Document 32:23 apply [2] - 7:12, 66:16 37:16, 38:6, 38:8, … 32:23 apply [2] - 7:12, 66:16 37:16, 38:6, 38:8, … 21 these patents. That gets cited repeatedly by the Patent 22 allegation from the contentions… clearly show that their 23 patents, we call it the '707 patent, okay, and what they do … 14 patents, for what purpose, to show them a list of documents 15 patent prosecution was External link to document
2020-04-27 394 Opinion infringement of U.S. Patent Nos. 9,265,831 (the #831 patent), 9,572,797 (the #797 patent), 9,144,568 (the #568 …#568 patent) and 9,597,399 (the #399 patent) by all defendants and infringement of U.S. Patent No. 9,572,887…asserted patents: claims 2, 3, and 5 of the #831 patent; and claims 9 and 11 of the #797 patent. Plaintiffs…asserted patents: claims 11, 18, and 22 of the #568 patent and claim 15 of the #399 patent (by all Defendants…claim 13 of the #399 patent (by Apotex only); and claim 13 of the #887 patent (by Slayback only). External link to document
2017-08-16 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,791,270 B2. (ceg) (Entered… 2017 6 July 2020 1:17-cv-01154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-07-06 406 Order - -Memorandum and Order all the patents that were asserted in the case by Plaintiffs except for U.S. Patent No. 8,791,270. The …respectively, with the exception of U.S. Patent No. 8,791,270, which has been resolved by the granting… 8,791,270, which has been resolved by the granting of a consent judgment." D.I. 319 ,r 4. …of the patent that has been asserted by Slayback in this case, with the exception of U.S. Patent No. 8,791,270…either infringe the asserted patents or don't infringe the asserted patents. I note in this regard that External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
Merck
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.